KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 103 filers reported holding KEROS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,517,277 | -49.4% | 62,650 | -46.2% | 0.01% | -54.5% |
| Q1 2023 | $4,975,404 | +1518.9% | 116,520 | +1720.6% | 0.01% | +1000.0% |
| Q4 2022 | $307,328 | -79.0% | 6,400 | -87.9% | 0.00% | -66.7% |
| Q2 2022 | $1,464,000 | +260.6% | 52,934 | +608.8% | 0.00% | +200.0% |
| Q1 2022 | $406,000 | +21.2% | 7,468 | +30.4% | 0.00% | 0.0% |
| Q4 2021 | $335,000 | -82.9% | 5,727 | -88.5% | 0.00% | -87.5% |
| Q3 2021 | $1,964,000 | +283.6% | 49,636 | +311.7% | 0.01% | +300.0% |
| Q2 2021 | $512,000 | +41.4% | 12,055 | +105.1% | 0.00% | 0.0% |
| Q1 2021 | $362,000 | -70.7% | 5,877 | -66.4% | 0.00% | -71.4% |
| Q4 2020 | $1,234,000 | – | 17,492 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 396,911 | $21,584,000 | 5.10% |
| Deep Track Capital, LP | 1,380,306 | $75,061,000 | 4.81% |
| Opaleye Management Inc. | 265,750 | $14,451,000 | 4.49% |
| Octagon Capital Advisors LP | 340,214 | $18,501,000 | 4.00% |
| First Light Asset Management, LLC | 658,145 | $35,790,000 | 3.16% |
| Altium Capital Management LP | 126,000 | $6,852,000 | 2.29% |
| Nantahala Capital Management | 816,830 | $44,419,000 | 1.96% |
| Orbimed Advisors | 1,679,417 | $91,327,000 | 1.48% |
| CHI Advisors LLC | 62,229 | $3,384,000 | 1.44% |
| Parkman Healthcare Partners LLC | 72,690 | $3,953,000 | 1.16% |